about
Dose dense carboplatin paclitaxel improves progression free survival in patients with endometrial cancer.Preterm delivery and future maternal risk of female malignancies.Is preterm delivery an independent risk factor for long-term maternal kidney disease?Fertility Treatments in Women Who Become Pregnant and Carried to Viability, and the Risk for Long-Term Maternal Cardiovascular Morbidity.Prepregnancy obesity: a risk factor for future development of ovarian and breast cancer.Preeclampsia and Future Risk for Maternal Ophthalmic Complications.Fertility treatments and the risk for ophthalmic complications: a cohort study with 25-year follow-up.Pre-eclampsia and Future Female Malignancy.The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up.Obesity in pregnancy: what's next? Long-term cardiovascular morbidity in a follow-up period of more than a decade.Gestational diabetes mellitus is a significant risk factor for long-term maternal renal disease.Long-term maternal atherosclerotic morbidity in women with pre-eclampsia.Maternal anemia during pregnancy and subsequent risk for cardiovascular disease.Outside the operating room: How a robotics program changed resource utilization on the inpatient Ward.Is stillbirth associated with long-term atherosclerotic morbidity?Recurrent pregnancy loss: a risk factor for long-term maternal atherosclerotic morbidity?Minimizing pain medication use and its associated costs following robotic surgery.Current strategies in the diagnosis of endometrial cancer.An association between preterm delivery and long-term maternal cardiovascular morbidity.Clinical and microbiological characteristics of Bartholin gland abscesses.Gestational diabetes mellitus is a significant risk factor for long-term ophthalmic morbidity.Bacteruria with group-B streptococcus: is it a risk factor for adverse pregnancy outcomes?The use of sonographic cervical length assessment for the prediction of time from induction to delivery.Is colonization with GBS in a previous pregnancy associated with adverse perinatal outcomes?Association between delivery of small-for-gestational-age neonate and long-term maternal chronic kidney disease.Obesity during pregnancy and long-term risk for ophthalmic morbidity - a population-based study with a follow-up of more than a decade.Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors.Risk factors predicting an emergency cesarean delivery for the second twin after vaginal delivery of the first twin.Placental abruption as a significant risk factor for long-term cardiovascular mortality in a follow-up period of more than a decade.Risk factors for relaparotomy after cesarean section.Can we find the perfect oil to protect the perineum? A randomized-controlled double-blind trial.Second stage disorders in patients following a previous cesarean section: vacuum versus repeated cesarean section.Obstetric and neonatal outcome in patients with anxiety disorders.Association between delivery of a small-for-gestational-age neonate and long-term maternal cardiovascular morbidity.The influence of visual impairment on pregnancy outcomes.Spinal versus general anesthesia in cesarean sections: the effects on postoperative pain perception.Preoperative analgesia with local lidocaine infiltration for post cesarean delivery pain management.Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer.Absence of cardiotoxicity with prolonged treatment and large accumulating doses of pegylated liposomal doxorubicin.An association between gestational diabetes mellitus and long-term maternal cardiovascular morbidity.
P50
Q38666130-650E39A1-1EE0-4D49-B083-ADE5A0C633A3Q38822540-DBCDAA08-7BDF-4FC7-ADE3-1C827B053627Q38849611-01CC1F1A-3271-4786-80F5-F19A00C9A091Q38869772-9177EA1C-7CE7-4211-BA27-54A600C7EE5FQ38904283-30B0C54B-1F7E-433B-8F1B-843180231BF2Q38908844-91CA22F5-6C0F-4106-BA96-E38D297FC234Q38928670-84FB2D82-722C-4385-9D46-5754F706BC41Q38961850-0D53941A-26C9-470A-A59A-81588F9CD120Q38967638-EFD21089-1280-4E92-ADB0-88891ED60609Q39033842-B35C7F6F-1FBC-4C07-89A7-189339A79BCCQ39041337-DEF4ADD1-2B9C-4E5A-BA89-211B5585289FQ39063459-1C8CD90F-7241-4C64-9F22-A0A5384FF178Q39120733-8047934B-699B-4645-83D3-2A07D2333FFBQ39124037-DD34AC70-E806-4D4A-86D1-780F32C1D234Q39152918-FA376C92-9D40-463A-B452-03042B43E2BCQ39179576-911AF9A3-FDD7-46C0-A36F-9B77B1DD9A28Q39191672-C9F4442B-F152-48C1-81AA-A819D4F0729DQ39309110-76DA5F65-D048-4FDF-AFC5-A7C420CBE0F7Q39396539-8B7F81FD-6E8E-4346-BFC0-753BA66F658CQ40232974-64A13DD3-3679-4374-9EF2-50CECE84FE24Q40252382-28029F7E-3D93-43DD-B197-BDCEAC85A812Q40289237-88CF43BE-F37E-4F07-BC71-3CAFAA9B80E3Q40326226-6A672536-B212-45F5-84D8-715432454C05Q40344299-3851A255-8115-413E-A53A-69B1F732781BQ41106978-16AB3130-59AA-4DC4-B22F-5FFE464D1C75Q41172087-3FC07114-2106-41DC-BE85-81AB35B5D030Q41468431-996061E4-E147-4F22-9653-E5ABF05EB36CQ41956402-38267AEE-1940-4721-8536-C6771F782CB0Q44394570-81671B78-A4AE-415E-8BE1-D6403544C5D9Q44541150-8400FE40-D6CF-4A64-BE81-03B70E9ADC5EQ45182921-2D83CBC8-9E2D-4056-915C-AE1E254A5FC0Q45365937-1C09B6DB-D4E1-4845-AB52-C4A8D39C62CAQ46318353-D53A1A5C-1EC1-4198-8482-1FB4A922B89FQ46319488-5AA8716C-C2A1-4527-9991-942102495350Q46334532-1714C6FB-5486-4586-8C61-F940A54DF37CQ48182446-2C56B9E1-FDF2-4235-AC4F-B18659E87F0CQ48230387-3F0E45AF-C6A5-4A34-96E4-F8551D6DCB36Q50209192-78B733DF-5BAF-4CD7-830A-42A4F9E13885Q50504945-97EC4CBF-E715-4E5C-8D57-29D9B1B0FC6EQ50848145-AC685031-93D2-4506-BCB5-98219A37B20C
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-2336-9973
@en
name
Roy Kessous
@ast
Roy Kessous
@en
Roy Kessous
@es
Roy Kessous
@nl
type
label
Roy Kessous
@ast
Roy Kessous
@en
Roy Kessous
@es
Roy Kessous
@nl
prefLabel
Roy Kessous
@ast
Roy Kessous
@en
Roy Kessous
@es
Roy Kessous
@nl
P106
P1153
36608159800
P31
P496
0000-0002-2336-9973